Literature DB >> 7554407

Endothelial cells and renal epithelial cells do not express the Wegener's autoantigen, proteinase 3.

W J King1, D Adu, M R Daha, C J Brooks, D J Radford, A A Pall, C O Savage.   

Abstract

Proteinase 3 (PR3) is the major antigen for autoantibodies (C-ANCA) against cytoplasmic components of neutrophils which are strongly associated with Wegener's granulomatosis (WG). Recent data that PR3 may be expressed by renal tubular epithelial cells and endothelial cells suggest potential for a direct pathogenic effect against these cells by C-ANCA or cytoxic T lymphocytes. Using a semi-quantitative polymerase chain reaction (PCR), ELISA and indirect immunofluorescence staining we studied endothelial and epithelial cell PR3 expression. By PCR, no PR3 expression was found in human umbilical vein endothelial cells (HUVEC) either untreated, or when treated with interferon-gamma (IFN-gamma) (200 U/ml, 6 h, 24 h), IL-1 (20 U/ml, 6 h), tumour necrosis factor-alpha, (TNF-alpha) (200 U/ml, 0, 1, 2, 4, 6 h) or IFN-gamma + TNF-alpha (6 h); iliac vein and artery endothelial cells did not express PR3 either. In contrast, PR3 was detected in HL60 cells and neutrophils by PCR, expression being confirmed by sequence analysis. Three PR3 MoAbs showed no binding to unstimulated or TNF-alpha-stimulated HUVEC either by ELISA or by indirect immunofluorescence staining. The epithelial cell line A549 expressed PR3 when assayed by PCR. However, three renal epithelial cell lines (two tubular and one glomerular) showed little or no PR3 expression by PCR or ELISA. These studies fail to demonstrate evidence for PR3 expression by endothelial cells, even when using the highly sensitive PCR assay. Whilst PR3 expression by A549 cells is intriguing, the relevance of this in the pathology of WG is doubtful considering the negligible expression by renal epithelial cell lines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554407      PMCID: PMC1553320          DOI: 10.1111/j.1365-2249.1995.tb06642.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

Review 1.  Culture of vascular endothelium.

Authors:  M A Gimbrone
Journal:  Prog Hemost Thromb       Date:  1976

2.  Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis.

Authors:  C O Savage; C G Winearls; S Jones; P D Marshall; C M Lockwood
Journal:  Lancet       Date:  1987-06-20       Impact factor: 79.321

3.  Permanent cell line expressing human factor VIII-related antigen established by hybridization.

Authors:  C J Edgell; C C McDonald; J B Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

4.  Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase.

Authors:  J L Niles; R T McCluskey; M F Ahmad; M A Arnaout
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

5.  A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells.

Authors:  M Lieber; B Smith; A Szakal; W Nelson-Rees; G Todaro
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

6.  Reactivity of anti-neutrophil cytoplasmic autoantibodies with HL-60 cells.

Authors:  L A Charles; R J Falk; J C Jennette
Journal:  Clin Immunol Immunopathol       Date:  1989-11

7.  An ultrastructural study of the pathogenesis of tissue injury in limited Wegener's granulomatosis.

Authors:  K J Donald; R L Edwards; J D McEvoy
Journal:  Pathology       Date:  1976-04       Impact factor: 5.306

8.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

9.  Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis.

Authors:  F J van der Woude; N Rasmussen; S Lobatto; A Wiik; H Permin; L A van Es; M van der Giessen; G K van der Hem; T H The
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

10.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.

Authors:  R J Falk; J C Jennette
Journal:  N Engl J Med       Date:  1988-06-23       Impact factor: 91.245

View more
  7 in total

Review 1.  Rare diseases.3: Wegener's granulomatosis.

Authors:  C A Langford; G S Hoffman
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

Review 2.  Combination therapy in autoimmune disease: vasculitis.

Authors:  D Carruthers; P Bacon
Journal:  Springer Semin Immunopathol       Date:  2001

Review 3.  Role of proteinase 3 in activation of endothelium.

Authors:  M E Taekema-Roelvink; C van Kooten; C A Verburgh; M R Daha
Journal:  Springer Semin Immunopathol       Date:  2001

4.  Urinary bladder cancer in Wegener's granulomatosis: is it more than cyclophosphamide?

Authors:  B Hellmich; I Kausch; C Doehn; D Jocham; K Holl-Ulrich; W L Gross
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

5.  Anti-proteinase-3 (PR3) antibodies (C-ANCA) recognize various targets on the human umbilical vein endothelial cell (HUVEC) membrane.

Authors:  M De Bandt; O Meyer; L Dacosta; C Elbim; C Pasquier
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

6.  Theodore E. Woodward Award. Do ANCA cause small vessel vasculitis?

Authors:  R J Falk
Journal:  Trans Am Clin Climatol Assoc       Date:  2001

7.  Anti-neutrophil cytoplasmic antibodies stimulate release of neutrophil microparticles.

Authors:  Ying Hong; Despina Eleftheriou; Abdullah A K Hussain; Fiona E Price-Kuehne; Caroline O Savage; David Jayne; Mark A Little; Alan D Salama; Nigel J Klein; Paul A Brogan
Journal:  J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 10.121

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.